Hillman L S, Salmons S, Dokoh S
Calcif Tissue Int. 1985 May;37(3):223-7. doi: 10.1007/BF02554867.
Serum 1,25(OH)2D concentrations were measured in serial serum samples from 19 premature infants of 29.6 +/- 1.3 weeks gestation and 1,129 +/- 159 g birthweight. 1,25(OH)2D was always normal or elevated and mean concentrations increased with age (adult, 55.2 +/- 13; infants, 1-2 weeks, 81.5 +/- 37.7 pg/mg; 3 weeks, 65 +/- 21; 6 weeks, 90.0 +/- 17.3; 9 weeks, 99.0 +/- 25.1; 12 weeks, 103.3 +/- 26.6 pg/ml). No correlation was seen with 25-OHD. Infants given 800 IU D2 supplements had lower 1,25(OH)2D levels than infants given 400 IU D2. Breast fed infants had initially higher 1,25(OH)2D levels; however, this was not sustained. These preliminary data suggest that premature infants regulate 1,25(OH)2D production similar to more mature infants and children. Whether the premature infant has a normal gastrointestinal and/or bone responsiveness to 1,25(OH)2D and whether these elevated 1,25(OH)2D concentrations are "adequately elevated" requires further study.
对19名孕周为29.6±1.3周、出生体重为1129±159克的早产儿的系列血清样本进行了血清1,25(OH)2D浓度测定。1,25(OH)2D水平始终正常或升高,且平均浓度随年龄增长而增加(成人,55.2±13;婴儿,1 - 2周,81.5±37.7 pg/mg;3周,65±21;6周,90.0±17.3;9周,99.0±25.1;12周,103.3±26.6 pg/ml)。未发现与25 - OHD有相关性。给予800 IU D2补充剂的婴儿的1,25(OH)2D水平低于给予400 IU D2的婴儿。母乳喂养的婴儿最初1,25(OH)2D水平较高;然而,这种情况并未持续。这些初步数据表明,早产儿调节1,25(OH)2D生成的方式与更成熟的婴儿和儿童相似。早产儿对1,25(OH)2D的胃肠道和/或骨骼反应是否正常,以及这些升高的1,25(OH)2D浓度是否“充分升高”,还需要进一步研究。